Literature DB >> 11927833

Polymorphisms in the methylenetetrahydrofolate reductase gene were associated with both the efficacy and the toxicity of methotrexate used for the treatment of rheumatoid arthritis, as evidenced by single locus and haplotype analyses.

Wako Urano1, Atsuo Taniguchi, Hisashi Yamanaka, Eiichi Tanaka, Hiroshi Nakajima, Yuko Matsuda, Hideto Akama, Yutaka Kitamura, Naoyuki Kamatani.   

Abstract

5,10-Methylenetetrahydrofolate reductase (MTHFR), a key enzyme involved in folate metabolism, has two common polymorphisms that affect enzyme activity. The objective of this study was to examine whether there was a correlation between the genotype or haplotype of the MTHFR gene and the efficacy or toxicity of methotrexate (MTX) in the treatment of rheumatoid arthritis. MTX-treated rheumatoid arthritis patients (n = 106) were selected from outpatient clinics and used for a retrospective study to examine the correlation between genotypes or haplotypes concerning polymorphisms of the MTHFR gene, and the efficacy or toxicity of MTX. Estimation of the haplotype frequencies was performed by maximum likelihood estimation based on expectation maximization algorithm. Single locus analysis examining each locus separately showed that patients with 1298C were receiving significantly lower doses of MTX compared to patients without [P < 0.05, relative risk (RR) = 2.18, 95% confidence interval (CI) 1.17-4.06], while a higher rate of overall MTX toxicity was observed in patients with 677T than those without (P < 0.05, RR = 1.25, 95% CI 1.05-1.49). An estimation of haplotype frequencies showed that there was no 677T-1298C haplotype in the population. Posterior distribution of the diplotype configuration for each individual was concentrated on a single configuration. Patients with the 677C-1298C haplotype were receiving lower doses of MTX than those without (P < 0.05, RR = 2.14, 95% CI 1.13-4.07), while subjects with 677T-1298A had a higher frequency of side-effects from MTX (P < 0.05, RR = 1.42, 95% CI 1.11-1.82). Both single locus and haplotype analyses suggest that polymorphisms within the MTHFR gene are associated with both the efficacy and toxicity of MTX in rheumatoid arthritis patients. Pharmacokinetic studies are necessary to prove the association.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11927833     DOI: 10.1097/00008571-200204000-00002

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


  64 in total

1.  Estimation of haplotype frequencies, linkage-disequilibrium measures, and combination of haplotype copies in each pool by use of pooled DNA data.

Authors:  Toshikazu Ito; Suenori Chiku; Eisuke Inoue; Makoto Tomita; Takayuki Morisaki; Hiroko Morisaki; Naoyuki Kamatani
Journal:  Am J Hum Genet       Date:  2003-01-17       Impact factor: 11.025

Review 2.  Drug-induced myelosuppression : diagnosis and management.

Authors:  Peter J Carey
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

3.  Large-scale single-nucleotide polymorphism (SNP) and haplotype analyses, using dense SNP Maps, of 199 drug-related genes in 752 subjects: the analysis of the association between uncommon SNPs within haplotype blocks and the haplotypes constructed with haplotype-tagging SNPs.

Authors:  Naoyuki Kamatani; Akihiro Sekine; Takuya Kitamoto; Aritoshi Iida; Susumu Saito; Akifumi Kogame; Eisuke Inoue; Manabu Kawamoto; Masayoshi Harigai; Yusuke Nakamura
Journal:  Am J Hum Genet       Date:  2004-06-16       Impact factor: 11.025

Review 4.  Pharmacogenetics in the rheumatic diseases.

Authors:  B N Cronstein
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

5.  Simultaneous estimation of haplotype frequencies and quantitative trait parameters: applications to the test of association between phenotype and diplotype configuration.

Authors:  Kyoko Shibata; Toshikazu Ito; Yutaka Kitamura; Naoko Iwasaki; Hiroshi Tanaka; Naoyuki Kamatani
Journal:  Genetics       Date:  2004-09       Impact factor: 4.562

Review 6.  The role of pharmacogenetics in nonmalignant gastrointestinal diseases.

Authors:  Michael Camilleri
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-07       Impact factor: 46.802

7.  Association test algorithm between a qualitative phenotype and a haplotype or haplotype set using simultaneous estimation of haplotype frequencies, diplotype configurations and diplotype-based penetrances.

Authors:  Toshikazu Ito; Eisuke Inoue; Naoyuki Kamatani
Journal:  Genetics       Date:  2004-12       Impact factor: 4.562

Review 8.  Advances in the molecular genetics of acute leukemia.

Authors:  Joseph M Scandura
Journal:  Curr Oncol Rep       Date:  2005-09       Impact factor: 5.075

Review 9.  Methotrexate pharmacogenomics.

Authors:  J M Kremer
Journal:  Ann Rheum Dis       Date:  2006-09       Impact factor: 19.103

10.  Genetic basis for adverse events after smallpox vaccination.

Authors:  David M Reif; Brett A McKinney; Alison A Motsinger; Stephen J Chanock; Kathryn M Edwards; Michael T Rock; Jason H Moore; James E Crowe
Journal:  J Infect Dis       Date:  2008-07-01       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.